culture
Sanidad rechaza de nuevo la financiación de los fármacos contra el alzhéimer precoz o con síntomas leves
By C. G. Real at El Mundo
· July 16, 2026
· 1 min read
Los medicamentos dirigidos a frenar los primeros signos de la demencia, Kisunla y Leqembi, no contarán con la cobertura económica del ministerio de Mónica García Leer
Por qué importa
Las noticias conectan a los lectores con su comunidad: las personas, los lugares y las decisiones que dan forma a la vida cotidiana. Latinas Media cubre estas historias para la comunidad latina porque los grandes medios a menudo no lo hacen.
Sobre esta historia
Original reporting by El Mundo . Latinas Media surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit El Mundo . Have a tip or correction? Contact our newsroom .
Category: culture ·
Published: July 16, 2026 ·
Source: El Mundo ·
Reading time: 1 min
Get more Latinas Media stories like this
Free weekly briefing covering culture and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? Los medicamentos dirigidos a frenar los primeros signos de la demencia, Kisunla y Leqembi, no contarán con la cobertura económica del ministerio de Mónica García Leer
When was this published? This article was first published on July 16, 2026 by El Mundo and curated for Latinas Media readers.
Who reported this story? This story was reported by C. G. Real at El Mundo. To learn more about how Latinas Media selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more culture coverage from Latinas Media, or browse our daily briefing and topic hubs .
← Back to all news
More culture →
Today’s briefing
Subscribe to newsletter